Cirrus D20: DigiTOF technology

Enabling prescription of targeted therapeutics / antibiotics for common infectious diseases

To help turn back AMR, the Cirrus D20 has been developed, allowing identification of microorganisms direct from patient samples without the need to culture

Empowering first and second line health care professionals to prescribe targeted antibiotics for common infectious diseases

Technology:
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Infection prevention
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Validation
  • Market entry
  • Research
  • Development
  • Marketed product

Organization:
  • Company
  • Government
  • Academia
  • Institute
  • NGO

Partnering:
  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:

    Infectious disease area:

      Geographic origin:


        Having expertise in the area of manufacturing, medical applications, business development

        BiosparQ is a high-tech start-up company (15 fte) located at the Bio Science parc in Leiden

        Other: expertise in the area of manufacturing, medical applications, business developme


        What is going on with AMR?
        Stay tuned with remarkable global AMR news and developments!